UPDATE: Baird Assumes Arrowhead Pharma (ARWR) at Neutral
Tweet Send to a Friend
(Updated - June 4, 2021 5:53 AM EDT)
Baird analyst Joel Beatty assumes coverage on Arrowhead Pharma (NASDAQ: ARWR) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty assumes coverage on Arrowhead Pharma (NASDAQ: ARWR) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE